Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3196128 | Dermatologic Clinics | 2008 | 5 Pages |
Abstract
A subject was enrolled in a multicenter, double-blinded clinical trial of ofloxacin-containing multidrug therapy for leprosy by the World Health Organization in 1992 and she developed multiple physical symptoms a few hours after taking the regimen. Physical examination and laboratory work-ups could not support a medical diagnosis and she was eventually dropped from the study. Decoding revealed that she belonged in the control group given the World Health Organization/multiple drug therapy–multibacillary regimen. In the course of treatment, she was diagnosed with conversion disorder and was subsequently treated with an antipsychotic.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Pearl Sherienne C. Legaspi, Ma. Luisa Abad Venida,